Literature DB >> 25805558

Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate.

Meredith Sadinski1, Milica Medved2, Ibrahim Karademir3,4, Shiyang Wang5, Yahui Peng6,7, Yulei Jiang8, Steffen Sammet9, Gregory Karczmar10, Aytekin Oto11.   

Abstract

PURPOSE: The purpose of the study is to determine short-term reproducibility of apparent diffusion coefficient (ADC) estimated from diffusion-weighted magnetic resonance (DW-MR) imaging of the prostate.
METHODS: Fourteen patients with biopsy-proven prostate cancer were studied under an Institutional Review Board-approved protocol. Each patient underwent two, consecutive and identical DW-MR scans on a 3T system. ADC values were calculated from each scan and a deformable registration was performed to align corresponding images. The prostate and cancerous regions of interest (ROIs) were independently analyzed by two radiologists. The prostate volume was analyzed by sextant. Per-voxel absolute and relative percentage variations in ADC were compared between sextants. Per-voxel and per-ROI variations in ADC were calculated for cancerous ROIs.
RESULTS: Per-voxel absolute difference in ADC in the prostate ranged from 0 to 1.60 × 10(-3) mm(2)/s (per-voxel relative difference 0% to 200%, mean 10.5%). Variation in ADC was largest in the posterior apex (0% to 200%, mean 11.6%). Difference in ADC variation between sextants was not statistically significant. Cancer ROIs' per-voxel variation in ADC ranged from 0.001 × 10(-3) to 0.841 × 10(-3) mm(2)/s (0% to 67.4%, mean 11.2%) and per-ROI variation ranged from 0 to 0.463 × 10(-3) mm(2)/s (mean 0.122 × 10(-3) mm(2)/s).
CONCLUSIONS: Variation in ADC within the human prostate is reasonably small, and is on the order of 10%.

Entities:  

Keywords:  ADC; DWI; MRI; Prostate; Reproducibility

Mesh:

Year:  2015        PMID: 25805558      PMCID: PMC4918747          DOI: 10.1007/s00261-015-0396-x

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  21 in total

1.  Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen.

Authors:  Adam C Braithwaite; Brian M Dale; Daniel T Boll; Elmar M Merkle
Journal:  Radiology       Date:  2008-12-18       Impact factor: 11.105

2.  Usefulness of diffusion-weighted imaging in the localization of prostate cancer.

Authors:  Hiroo Kajihara; Yoshiko Hayashida; Ryuji Murakami; Kazuhiro Katahira; Ryuichi Nishimura; Yasuyuki Hamada; Kousuke Kitani; Mitsuhiko Kitaoka; Yasuko Suzuki; Mika Kitajima; Toshinori Hirai; Shoji Morishita; Kazuo Awai; Yasuyuki Yamashita
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-18       Impact factor: 7.038

3.  Independent association of angiogenesis index with outcome in prostate cancer.

Authors:  R Mehta; A Kyshtoobayeva; T Kurosaki; E J Small; H Kim; R Stroup; C E McLaren; K T Li; J P Fruehauf
Journal:  Clin Cancer Res       Date:  2001-01       Impact factor: 12.531

4.  Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies.

Authors:  Thomas L Chenevert; Craig J Galbán; Marko K Ivancevic; Susan E Rohrer; Frank J Londy; Thomas C Kwee; Charles R Meyer; Timothy D Johnson; Alnawaz Rehemtulla; Brian D Ross
Journal:  J Magn Reson Imaging       Date:  2011-10       Impact factor: 4.813

5.  Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.

Authors:  Aytekin Oto; Cheng Yang; Arda Kayhan; Maria Tretiakova; Tatjana Antic; Christine Schmid-Tannwald; Scott Eggener; Gregory S Karczmar; Walter M Stadler
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

6.  Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.

Authors:  Courtney A Woodfield; Glenn A Tung; David J Grand; John A Pezzullo; Jason T Machan; Joseph F Renzulli
Journal:  AJR Am J Roentgenol       Date:  2010-04       Impact factor: 3.959

7.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.

Authors:  Bashar Issa
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

8.  Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue.

Authors:  Keyanoosh Hosseinzadeh; Samuel David Schwarz
Journal:  J Magn Reson Imaging       Date:  2004-10       Impact factor: 4.813

9.  Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness.

Authors:  Geert J S Litjens; Thomas Hambrock; Christina Hulsbergen-van de Kaa; Jelle O Barentsz; Henkjan J Huisman
Journal:  Radiology       Date:  2012-08-24       Impact factor: 11.105

10.  Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.

Authors:  Hyun Kyung Lim; Jeong Kon Kim; Kyung Ah Kim; Kyoung-Sik Cho
Journal:  Radiology       Date:  2008-11-18       Impact factor: 11.105

View more
  14 in total

1.  Post Hoc Analysis of Passive Cavitation Imaging for Classification of Histotripsy-Induced Liquefaction in Vitro.

Authors:  Kenneth B Bader; Kevin J Haworth; Adam D Maxwell; Christy K Holland
Journal:  IEEE Trans Med Imaging       Date:  2017-08-02       Impact factor: 10.048

2.  Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging.

Authors:  Teodora Szasz; Grace Lee; Aritrick Chatterjee; Milica Medved; Ajit Devaraj; Ambereen Yousuf; Xiaobing Fan; Gregory S Karczmar; Aytekin Oto
Journal:  Abdom Radiol (NY)       Date:  2022-05-18

3.  Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).

Authors:  Michael A Boss; Bradley S Snyder; Eunhee Kim; Dena Flamini; Sarah Englander; Karthik M Sundaram; Naveen Gumpeni; Suzanne L Palmer; Haesun Choi; Adam T Froemming; Thorsten Persigehl; Matthew S Davenport; Dariya Malyarenko; Thomas L Chenevert; Mark A Rosen
Journal:  J Magn Reson Imaging       Date:  2022-02-10       Impact factor: 5.119

Review 4.  The expanding landscape of diffusion-weighted MRI in prostate cancer.

Authors:  Andreas G Wibmer; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2016-05

5.  Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer.

Authors:  Harri Merisaari; Pekka Taimen; Rakesh Shiradkar; Otto Ettala; Marko Pesola; Jani Saunavaara; Peter J Boström; Anant Madabhushi; Hannu J Aronen; Ivan Jambor
Journal:  Magn Reson Med       Date:  2019-11-08       Impact factor: 4.668

6.  Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.

Authors:  Andriy Fedorov; Mark G Vangel; Clare M Tempany; Fiona M Fennessy
Journal:  Invest Radiol       Date:  2017-09       Impact factor: 6.016

7.  Repeatability of Multiparametric Prostate MRI Radiomics Features.

Authors:  Michael Schwier; Joost van Griethuysen; Mark G Vangel; Steve Pieper; Sharon Peled; Clare Tempany; Hugo J W L Aerts; Ron Kikinis; Fiona M Fennessy; Andriy Fedorov
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

8.  An annotated test-retest collection of prostate multiparametric MRI.

Authors:  Andriy Fedorov; Michael Schwier; David Clunie; Christian Herz; Steve Pieper; Ron Kikinis; Clare Tempany; Fiona Fennessy
Journal:  Sci Data       Date:  2018-12-04       Impact factor: 6.444

9.  Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals.

Authors:  Ricardo Donners; Raphael Shih Zhu Yiin; Dow-Mu Koh; Katja De Paepe; Ian Chau; Sue Chua; Matthew D Blackledge
Journal:  Quant Imaging Med Surg       Date:  2021-08

10.  Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.

Authors:  Thais Caldara Mussi; Tatiana Martins; Adriano Tachibana; Pedro Nogueira Mousessian; Ronaldo Hueb Baroni
Journal:  Int Braz J Urol       Date:  2018 Sep-Oct       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.